Kiora Pharmaceuticals
KPRX
4 hedge funds and large institutions have $275K invested in Kiora Pharmaceuticals in 2016 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 2 closing their positions.
20% less funds holding
Funds holding: 5 → 4 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
72% less capital invested
Capital invested by funds: $987K → $275K (-$712K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$154K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$30.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$624K |
| 2 |
AIC
AWM Investment Company
New York
|
-$292K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Vanguard Group
Malvern,
Pennsylvania
| $197K | +$154K | +10 | +500% |
|
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $35K | +$30.9K | +2 | New |
|
|
VIA
3
Vantage Investment Advisors
State College,
Pennsylvania
| $20K | – | – | – |
|
4
Morgan Stanley
New York
| $16K | – | – | – |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| $3K | – | – | – |
|
6
Bank of America
Charlotte,
North Carolina
| $2K | – | – | – |
|
7
UBS Group
Zurich,
Switzerland
| $2K | – | – | – |
|
|
SM
8
Sabby Management
Miami Beach,
Florida
| – | -$624K | -42 | Closed |
|
|
AIC
9
AWM Investment Company
New York
| – | -$292K | -20 | Closed |
|
KPRX Hedge Fund Activity: Q1 2016 in Review
4 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Kiora Pharmaceuticals (KPRX) for Q1 2016, worth a combined $275K — down 72% from $987K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of KPRX and 1 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.
The largest buyer was Vanguard Group, adding an estimated $154K. The largest seller was Sabby Management, exiting entirely with an estimated $624K sold.
- 4 institutional investors held Kiora Pharmaceuticals (KPRX) as of Q1 2016, down from 5 in Q4 2015.
- Funds reported $275K of Kiora Pharmaceuticals stock for Q1 2016, down 72% quarter-over-quarter.
- 1 fund opened new Kiora Pharmaceuticals positions in Q1 2016 and 2 closed out, a net change of -1 holder.
- The largest Kiora Pharmaceuticals buyer in Q1 2016 was Vanguard Group, an estimated $154K added.
- The largest Kiora Pharmaceuticals seller in Q1 2016 was Sabby Management, an estimated $624K sold.
Based on aggregated 13F filings for Q1 2016.